Fig. 1From: The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patientsStudy design. JDM juvenile dermatomyositis, PDN prednisone, MTX methotrexate, CSA cyclosporine, pts patients, CR clinical remission, TF treatment failureBack to article page